Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
Public ClinicalTrials.gov record NCT02296164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valchlor®
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Valchlor PROVe study is a multi-center, prospective, observational, US-based drug study that longitudinally follows patients with Mycosis Fungoides Cutaneous T-cell Lymphoma (MF-CTCL) who are receiving therapy with Valchlor. Patients will be followed prospectively for a maximum of 2 years from the date of signed informed consent (enrollment) until end of study. Continuation in the study is not contingent on continuation of Valchlor.
Study identification
- NCT ID
- NCT02296164
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2014 (Actual)
- Primary completion
- Oct 17, 2018 (Actual)
- Completion
- Oct 17, 2018 (Actual)
- Last update posted
- Mar 4, 2020
2014 – 2018
United States locations
- U.S. sites
- 36
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site | Little Rock | Arkansas | 72205 | — |
| Investigator Site | Duarte | California | 91010 | — |
| Investigator Site | La Mesa | California | 91941 | — |
| Investigator Site | San Francisco | California | 94115 | — |
| Investigator Site | Santa Ana | California | 92701 | — |
| Investigator Site | Aurora | Colorado | 80045 | — |
| Investigator Site | New Haven | Connecticut | 06520 | — |
| Investigator Site | Coral Gables | Florida | 33134 | — |
| Investigator Site | Hollywood | Florida | 33021 | — |
| Investigator Site | Naples | Florida | 34102 | — |
| Investigator Site | Tampa | Florida | 33612 | — |
| Investigator Site | Atlanta | Georgia | 30328 | — |
| Investigator Site | Chicago | Illinois | 60611 | — |
| Investigator Site | Chicago | Illinois | 60612 | — |
| Investigator Site | Chicago | Illinois | 60637 | — |
| Investigator Site | New Orleans | Louisiana | 70112 | — |
| Investigator Site | Boston | Massachusetts | 02215 | — |
| Investigator Site | Ann Arbor | Michigan | 48103 | — |
| Investigator Site | Jackson | Mississippi | 39216 | — |
| Investigator Site | St Louis | Missouri | 63104 | — |
| Investigator Site | St Louis | Missouri | 63110 | — |
| Investigator Site | Henderson | Nevada | 89074 | — |
| Investigator Site | East Windsor | New Jersey | 08520 | — |
| Investigator Site | Brooklyn | New York | 11203 | — |
| Investigator Site | Fairport | New York | 14450 | — |
| Investigator Site | New York | New York | 10032 | — |
| Investigator Site | The Bronx | New York | 10467 | — |
| Investigator Site | Cleveland | Ohio | 44106 | — |
| Investigator Site | Exton | Pennsylvania | 19341 | — |
| Investigator Site | Philadelphia | Pennsylvania | 19104 | — |
| Investigator Site | Philadelphia | Pennsylvania | 19107 | — |
| Investigator Site | Pittsburgh | Pennsylvania | 15213 | — |
| Investigator Site | Charleston | South Carolina | 29414 | — |
| Investigator Site | Dallas | Texas | 75231 | — |
| Investigator Site | Dallas | Texas | 75390 | — |
| Investigator Site | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02296164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02296164 live on ClinicalTrials.gov.